Article info
PDFEmerging technologies and therapeutics
Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin
- Correspondence to Dr Philip A Levin; pal3420{at}yahoo.com
Citation
Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin
Publication history
- Received March 17, 2016
- Revised May 3, 2016
- Accepted June 3, 2016
- First published August 26, 2016.
Online issue publication
January 03, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/